483 results on '"Krause, Bernd-J."'
Search Results
52. Tolerability of [177Lu]Lu-PSMA-617 by treatment exposure in patients with metastatic castration-resistant prostate cancer (mCRPC): A VISION study subgroup analysis.
53. Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer
54. Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study.
55. Olfactory Bulb D2/D3 Receptor Availability after Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson’s Disease
56. CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1
57. Cardiac FDG-PET: a straight forward tool with high potential
58. DGN-Handlungsempfehlung (S1-Leitlinie) – PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms – Stand: 01/2022 – AWMF-Registernummer: 031-055.
59. A 2022 International Survey on the Status of Prostate Cancer Theranostics.
60. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F]F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation
61. Evidence of a modality-dependent role of the cerebellum in working memory? An fMRI study comparing verbal and abstract n-back tasks
62. Joint independent component analysis of structural and functional images reveals complex patterns of functional reorganisation in stroke aphasia
63. Standardization of MRI and Amyloid Imaging
64. List of Contributors
65. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
66. Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
67. Impact of the COVID-19 pandemic on nuclear medicine departments in Europe
68. 68Ga-labelled tropane analogues for the visualization of the dopaminergic system
69. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status
70. Impact of the COVID-19 pandemic on nuclear medicine departments in Europe.
71. Impact of the COVID-19 pandemic on nuclear medicine departments in Europe
72. Comparison of Different SUV-Based Methods for Response Prediction to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer by FDG-PET and MRI
73. Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer
74. [ 11C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer
75. [11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model
76. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
77. Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment
78. Der Chemokinrezeptor CXCR4 – seine Entwicklung und Bedeutung in der nuklearmedizinischen Theranostik
79. Multimodal Imaging Techniques to Evaluate the Anticancer Effect of Cold Atmospheric Pressure Plasma
80. 2022 INTERNATIONAL SURVEY ON THE STATUS OF PROSTATE CANCER THERANOSTICS.
81. Early post-ischemic glucose metabolism is dependent on function of TLR2: a study using [18F]FDG PET-CT in a mouse model of cardiac arrest and cardiopulmonary resuscitation
82. Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice
83. Neuroprotective Effects of the FGF21 Analogue LY2405319
84. PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen: Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krankenhaussektor
85. Regulatorische Anforderungen an Radiopharmaka in Deutschland: die Fachgesellschaft im behördlichen Dialog
86. Principles and Practice of PET/CT Part 2
87. PET and PET–CT in Esophageal and Gastric Cancer
88. Early Post-ischemic Brain Glucose Metabolism Is Dependent on Function of TLR2: a Study Using [18F]F-FDG PET-CT in a Mouse Model of Cardiac Arrest and Cardiopulmonary Resuscitation.
89. PET/CT for the diagnosis, staging and restaging of prostate cancer
90. 68 Ga‐Labelled Tropane Analogues for the Visualization of the Dopaminergic System
91. VISION: An international, prospective, open-label, multicenter, randomized phase III study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
92. Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A sub-study of the VISION trial.
93. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status
94. PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed
95. Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers
96. Human monoclonal antibody99mTc-88BV59: Detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment
97. [Dopamine Transporter SPECT with I-123 labelled FP-CIT (DaTSCANTM)]
98. Systems level modeling of a neuronal network subserving intrinsic alertness
99. Markov random field segmentation of brain MR images
100. Fludeoxyglucose F 18 Positron Emission Tomography and Computed Tomography of a Giant Retroperitoneal Schwannoma Occurring in a Patient With Neurofibromatosis Type 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.